Showing results (1131-1140 of 6,130) with videos related to
Sort By:
Pageof 613
International Journal of Antimicrobial Agents|September 28, 2020
Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamicsArafat Rahman Oany, Mamun Mia, Tahmina Pervin, et al.International Journal of Antimicrobial Agents|January 2, 2021
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazineMarion Plaze, David Attali, Matthieu Prot, et al.International Journal of Antimicrobial Agents|December 28, 2020
Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal PrecisionHubert C Chua, Andy Tse, Nicholas M Smith, et al.International Journal of Antimicrobial Agents|December 18, 2020
Early clinical outcomes with tocilizumab for severe COVID-19: a two-centre retrospective studySteven M Smoke, Karan Raja, Patrick Hilden, et al.International Journal of Antimicrobial Agents|October 20, 2020
Preferences regarding antibiotic treatment and the role of antibiotic resistance: A discrete choice experimentM Ancillotti, S Eriksson, D I Andersson, et al.International Journal of Antimicrobial Agents|December 14, 2020
Vertical transmission and kidney damage in newborns whose mothers had coronavirus disease 2019 during pregnancyZheng He, Yinian Fang, Qin Zuo, et al.International Journal of Antimicrobial Agents|January 29, 2020
Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a reviewSoraya Silva Santos, Renan Vinicius de Araújo, Jeanine Giarolla, et al.International Journal of Antimicrobial Agents|December 1, 2020
Hydroxychloroquine lung pharmacokinetics in critically ill patients with COVID-19S Ruiz, D Concordet, T Lanot, et al.International Journal of Antimicrobial Agents|December 2, 2020
Clinical impact of cefepime breakpoint in patients with carbapenem-resistant Klebsiella pneumoniae bacteraemiaNan-Yao Lee, Ching-Lung Lo, Po-Lin Chen, et al.International Journal of Antimicrobial Agents|January 9, 2022
Alterins, a new family of marine antibacterial cyclolipopeptidesClément Offret, Héléna Cuny, Pierre-Edouard Bodet, et al.Pageof 613